Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at KeyCorp dropped their FY2017 earnings per share (EPS) estimates for Acadia Healthcare in a research note issued on Tuesday. KeyCorp analyst J. Gurda now forecasts that the company will post earnings of $2.41 per share for the year, down from their previous estimate of $2.44. KeyCorp has a “Buy” rating and a $59.00 price objective on the stock.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. The business’s revenue for the quarter was down 5.4% on a year-over-year basis. TRADEMARK VIOLATION NOTICE: This article was first posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/10/20/acadia-healthcare-company-inc-forecasted-to-post-fy2017-earnings-of-2-41-per-share-achc.html.

Several other analysts have also recently commented on ACHC. William Blair began coverage on shares of Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating for the company. BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 1st. Mizuho lifted their price objective on shares of Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Deutsche Bank AG lifted their price objective on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $57.64.

Acadia Healthcare (NASDAQ ACHC) traded up 0.88% during midday trading on Friday, hitting $44.55. 251,366 shares of the stock were exchanged. The company has a market cap of $3.91 billion, a PE ratio of 489.56 and a beta of 1.07. The firm’s 50 day moving average price is $45.72 and its 200 day moving average price is $46.29. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.34.

A number of hedge funds have recently made changes to their positions in ACHC. Teacher Retirement System of Texas lifted its position in shares of Acadia Healthcare by 0.4% during the second quarter. Teacher Retirement System of Texas now owns 5,949 shares of the company’s stock worth $294,000 after purchasing an additional 26 shares in the last quarter. Public Employees Retirement Association of Colorado lifted its position in shares of Acadia Healthcare by 0.9% during the second quarter. Public Employees Retirement Association of Colorado now owns 17,798 shares of the company’s stock worth $879,000 after purchasing an additional 160 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Acadia Healthcare by 2.2% during the second quarter. Pacer Advisors Inc. now owns 10,365 shares of the company’s stock worth $512,000 after purchasing an additional 226 shares in the last quarter. People s United Financial Inc. lifted its position in shares of Acadia Healthcare by 3.4% during the second quarter. People s United Financial Inc. now owns 7,459 shares of the company’s stock worth $368,000 after purchasing an additional 242 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after purchasing an additional 270 shares in the last quarter.

In other Acadia Healthcare news, President Brent Turner sold 206,252 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William Grieco sold 2,000 shares of the stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $51.71, for a total transaction of $103,420.00. Following the transaction, the director now directly owns 45,013 shares of the company’s stock, valued at approximately $2,327,622.23. The disclosure for this sale can be found here. Insiders have sold 3,085,693 shares of company stock valued at $157,729,099 in the last ninety days. Insiders own 11.10% of the company’s stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.